As Pandemic Wanes, Firms That Rode C0VID-19 Testing Wave Struggle for Solid Footing

Companies that once rode high on the COVID-19 pandemic may now have to face the possibility of extinction in the coming years.

Article By Greg Cima / March 7, 2023

Companies that once rode high on the COVID-19 pandemic may now have to face the possibility of extinction in the coming years.

View PDF

Resources

Outcome Capital Congratulates Elios Vision on the Acquisition by Bausch + Lomb

Outcome’s strategic advisory and investment banking played a critical role in the inception, growth and success of ELIOS Vision

Download
Resources

Outcome Capital Life Science Market Pulse, December 2024

Outcome Capital Life Science Market Pulse December 2024 Click to view our LifeSciences Pulse Newsletter

Download

Contact Us for More Information

Would you like to learn more about working with Outcome Capital or discuss your specific needs?

Contact Us

  • Boston

    20 Custom House St, Suite 1200, Boston, MA 02110
    (617) 431-2278

© Outcome Capital 2025. Member of Financial Industry Regulatory Authority (FINRA) and the Securities Investment Protection Corporation (SIPC). Check the background of this firm on FINRA’s BrokerCheck.

Business Continuity Plan | Privacy Policy | Regulation Best Interest

Built by Metropolis